AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally.
It operates through Lifecore, Curation Foods, and Other segments.
The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures.
It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products.
This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets.
The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels.
The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022.
Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.
Country | United States |
IPO Date | Feb 15, 1996 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 524 |
CEO | Paul Josephs |
Contact Details
Address: 3515 Lyman Boulevard Chaska, Minnesota United States | |
Website | https://www.lifecore.com |
Stock Details
Ticker Symbol | LFCR |
Exchange | NASDAQ |
Fiscal Year | June - May |
Reporting Currency | USD |
CIK Code | 0001005286 |
CUSIP Number | n/a |
ISIN Number | US5147661046 |
Employer ID | 94-3025618 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Paul Josephs | President, Chief Executive Officer & Director |
Ryan D. Lake CPA | Chief Financial Officer & Secretary |
Aaron Perlitsh | Director of Internal Audit & Chief Compliance Officer |
Brikkelle Thompson | Senior Vice President of Human Resources |
Darren M. Hieber | Senior Vice President of Corporate Development & Partnerships |
Dr. Albert D. Bolles Ph.D. | President of Curation Foods, Inc. |
Jackie Q. Klecker | Executive Vice President, Quality and Development Services & GM |
James G. Hall | Advisor |
Matt Augustson | Senior Vice President of Information Technology |
Parker K. Javid | Vice President |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 08, 2025 | 4 | Filing |
Jan 07, 2025 | 8-K | Current Report |
Jan 02, 2025 | 10-Q | Quarterly Report |
Jan 02, 2025 | 8-K | Current Report |
Dec 26, 2024 | SCHEDULE 13D/A | [Amend] Filing |
Dec 10, 2024 | 4 | Filing |
Dec 10, 2024 | 4 | Filing |
Nov 26, 2024 | 8-K | Current Report |
Nov 21, 2024 | 8-K | Current Report |
Nov 08, 2024 | 8-K | Current Report |